Ji M. Zhu

168 Changhai Road
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 138 publications

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Journal: Current treatment options in oncology

Published: May 17, 2026

Deep learning-based computed tomography quantification integrated with circulating tumor cells for prognostic evaluation in stage I lung adenocarcinoma.

Deep learning-based computed tomography quantification integrated with circulating tumor cells for prognostic evaluation in stage I lung adenocarcinoma.

Journal: Quantitative imaging in medicine and surgery

Published: November 06, 2025

Rectal delivered nanocomposite suppository against radiation-induced proctitis.

Rectal delivered nanocomposite suppository against radiation-induced proctitis.

Journal: Journal of nanobiotechnology

Published: November 03, 2025

snRNA-seq of acral melanoma reveals heterogeneity and identifies novel progression marker and cancer-associated fibroblasts subpopulation.

snRNA-seq of acral melanoma reveals heterogeneity and identifies novel progression marker and cancer-associated fibroblasts subpopulation.

Journal: NPJ precision oncology

Published: October 04, 2025

A preliminary profile of RNA bound on the cell surface.

A preliminary profile of RNA bound on the cell surface.

Journal: Chemical science

Published: August 01, 2025

Development and validation of a post-chemoradiotherapy prognostic model in patients with locally advanced rectal cancer who underwent radical surgery after neoadjuvant chemoradiotherapy: a retrospective, multicenter, cohort study.

Development and validation of a post-chemoradiotherapy prognostic model in patients with locally advanced rectal cancer who underwent radical surgery after neoadjuvant chemoradiotherapy: a retrospective, multicenter, cohort study.

Journal: International journal of surgery (London, England)

Published: July 17, 2025

Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy.

Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy.

Journal: Molecular cancer

Published: June 16, 2025

Molecular mechanisms of TAM-regulated tumorigenesis and progression in various types of radiotherapy and future prospects of radiation-immunotherapy combinations.

Molecular mechanisms of TAM-regulated tumorigenesis and progression in various types of radiotherapy and future prospects of radiation-immunotherapy combinations.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: May 05, 2025

Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial.

Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial.

Journal: Cancer communications (London, England)

Published: April 24, 2025

Patients-Derived Organoids Sequencing-based FOXP4 Facilitates Radioresistance by Transcriptionally Modifying GPX4 to Regulate ferroptosis in Colorectal Cancer.

Patients-Derived Organoids Sequencing-based FOXP4 Facilitates Radioresistance by Transcriptionally Modifying GPX4 to Regulate ferroptosis in Colorectal Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 18, 2025

Minimum sample size calculation for radiomics-based binary outcome prediction models: Theoretical framework and practical example.

Minimum sample size calculation for radiomics-based binary outcome prediction models: Theoretical framework and practical example.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 06, 2025

A Bionic "Trojan Horse"-like Nanovesicle Delivery System Hybridized with BCG Cytoplasmic Membrane and Melanoma Cell Membrane for Cancer Immunotherapy.

A Bionic "Trojan Horse"-like Nanovesicle Delivery System Hybridized with BCG Cytoplasmic Membrane and Melanoma Cell Membrane for Cancer Immunotherapy.

Journal: Pharmaceutics

Published: February 07, 2025

Showing 1-12 of 138

Last Updated: 09/26/2026